Phase 3 Triiodothyronine Supplementation for Infants After Cardiopulmonary Bypass

NCT02320669 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

220

Enrollment

OTHER

Sponsor class

Conditions

Congenital Heart Defects

Interventions

DRUG: Triostat
DRUG: Placebo

Sponsor

Seattle Children's Hospital